BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Lumefantrine

A fluorene derivative that is used in combination with ARTEMETHER for the treatment of MALARIA (see ARTEMETHER-LUMEFANTRINE DRUG COMBINATION).

299+ PubMed studies analyzed · 62 RCTs · Evidence Score: 52.2

Research Domains

Lumefantrine has been studied across 8 research domains including ⚡ Energy & Fatigue, 🧠 Focus & Attention, 🔥 Metabolic, 🫁 Liver & Detox, 🔬 Oncology. The primary research focus is ⚡ Energy & Fatigue with 9% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lumefantrine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Melphalan
19 shared targets
Robenidine
10 shared targets
Thioinosine
10 shared targets
Aprepitant
14 shared targets
Itraconazole
10 shared targets
Isopentenyladenosine
10 shared targets
deguelin
9 shared targets
Betamethasone
10 shared targets
Dimethisterone
9 shared targets
Oxymetholone
13 shared targets
Loading evidence profile...

This evidence profile for Lumefantrine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.